Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Damon Reed, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator - Julio M. Barredo, M.D.
Holtz Children's Hospital University of Miami Miller School of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Holtz Children'S Hospital University of Miami Miller School of Medicine
Miami, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Montefiore Medical Center, the Children'S Hospital at Montefiore
The Bronx, New York, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jul 2011
- Primary completion
- 16 Nov 2016
- Completion
- 27 Jul 2017
- Last update posted
- 7 Aug 2017
- Registered enrollment
- 14
- Registry id
- NCT01324180
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.